FDA clears a LivaNova 510(k) for B-Capta, an in-line, blood-gas monitoring system integrated into its S5 heart-lung machine.
FDA clears a Johnson & Johnson Vision 510(k) for its Veritas Vision System, a phacoemulsification (cataract surgery) device that allows surgeons to gu...
Two Yale Law School professors suggest changes to FDA to create a clinical trial publicity regime exposing confidential data.
CBER director Peter Marks says enforcement discretion for IND and premarket application requirements for certain regenerative medicine products will n...
FDA grants Allogene Therapeutics a Regenerative Medicine Advanced Therapy designation for ALLO-715 and its use in relapsed/refractory multiple myeloma...
The International Council for Harmonization publishes a draft version of its E6 good clinical practice guideline.
A European Medicines Agency safety review says Johnson & Johnsons Covid-19 vaccine continues to have a favorable benefit-risk profile but it should ca...
FDA places a clinical hold on a KalVista Pharmaceuticals proposed Phase 2 clinical trial of KVD824 for preventing hereditary angioedema attacks.